ES2175152T3 - Fosfolipidos protectores de las radiaciones. - Google Patents
Fosfolipidos protectores de las radiaciones.Info
- Publication number
- ES2175152T3 ES2175152T3 ES96940103T ES96940103T ES2175152T3 ES 2175152 T3 ES2175152 T3 ES 2175152T3 ES 96940103 T ES96940103 T ES 96940103T ES 96940103 T ES96940103 T ES 96940103T ES 2175152 T3 ES2175152 T3 ES 2175152T3
- Authority
- ES
- Spain
- Prior art keywords
- phospholipids
- derivatized
- disclosed
- ether
- radiation protective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000003904 phospholipids Chemical class 0.000 title abstract 3
- 230000001681 protective effect Effects 0.000 title 1
- 230000005855 radiation Effects 0.000 title 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 4
- 239000000232 Lipid Bilayer Substances 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 125000003827 glycol group Chemical group 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003020 moisturizing effect Effects 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/335—Polymers modified by chemical after-treatment with organic compounds containing phosphorus
- C08G65/3353—Polymers modified by chemical after-treatment with organic compounds containing phosphorus containing oxygen in addition to phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Luminescent Compositions (AREA)
- Radiation-Therapy Devices (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
SE EXPONEN NUEVOS FOSFOLIPIDOS VINCULADOS AL ETER, OBTENIDOS COMO DERIVACION CON POLIETILENGLICOL EN EL GRUPO DE LA CABEZA POLAR. LAS DOBLES CAPAS DE LIPIDOS QUE CONTIENEN ESTOS FOSFOLIPIDOS MUESTRAN UNA ELEVADA ESTABILIDAD OSCILATIVA. SE EXPONE IGUALMENTE EL USO DE LIPIDOS VINCULADOS AL ETER Y DERIVADOS DEL PEG EN COMPOSICIONES COSMETICAS HIDRATANTES Y PARA PROTECCION CONTRA LAS RADIACIONES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/570,440 US5817856A (en) | 1995-12-11 | 1995-12-11 | Radiation-protective phospholipid and method |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2175152T3 true ES2175152T3 (es) | 2002-11-16 |
Family
ID=24279658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96940103T Expired - Lifetime ES2175152T3 (es) | 1995-12-11 | 1996-12-10 | Fosfolipidos protectores de las radiaciones. |
Country Status (8)
Country | Link |
---|---|
US (2) | US5817856A (es) |
EP (1) | EP0900075B1 (es) |
AT (1) | ATE215360T1 (es) |
AU (1) | AU705529B2 (es) |
DE (1) | DE69620473T2 (es) |
ES (1) | ES2175152T3 (es) |
IL (1) | IL124732A0 (es) |
WO (1) | WO1997021429A1 (es) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5817856A (en) * | 1995-12-11 | 1998-10-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Radiation-protective phospholipid and method |
US6306433B1 (en) * | 1997-08-12 | 2001-10-23 | Pharmacia Ab | Method of preparing pharmaceutical compositions |
US20040247662A1 (en) * | 1998-06-25 | 2004-12-09 | Dow Steven W. | Systemic immune activation method using nucleic acid-lipid complexes |
US20030022854A1 (en) | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
US20030017183A1 (en) * | 2000-01-11 | 2003-01-23 | Pollock David E. | Dermatological suspensions(micro-matrix) |
ES2230268T3 (es) * | 2000-02-10 | 2005-05-01 | Liplasome Pharma A/S | Sistema de liberacion de farmacos basados en lipidos. |
US20050129722A1 (en) * | 2002-03-13 | 2005-06-16 | Collagenex Pharmaceuticals, Inc. | Water-based delivery systems |
NZ534377A (en) * | 2002-03-13 | 2008-04-30 | Collagenex Pharm Inc | Water-based topical delivery system consisting of cholesterol, fatty acids water and a phospholipid/ceramide portion. |
ITMI20021033A1 (it) * | 2002-05-15 | 2003-11-17 | Acraf | Composizione oftalmica acquosa comprendente un lipide mesomorfico liotropico |
DE60334618D1 (de) | 2002-06-28 | 2010-12-02 | Protiva Biotherapeutics Inc | Verfahren und vorrichtung zur herstellung von liposomen |
US7939170B2 (en) * | 2002-08-15 | 2011-05-10 | The Rockefeller University | Water soluble metal and semiconductor nanoparticle complexes |
US7655772B2 (en) | 2002-09-06 | 2010-02-02 | University Of South Florida | Materials and methods for treatment of allergic diseases |
US20080214437A1 (en) * | 2002-09-06 | 2008-09-04 | Mohapatra Shyam S | Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases |
US20040166083A1 (en) * | 2003-02-26 | 2004-08-26 | The Andrew Jergens Company | Personal care water-in-oil emulsion products |
EP1610763A2 (en) * | 2003-03-31 | 2006-01-04 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Stable liposomes or micelles comprising a sphingolipid and a peg-lipopolymer |
CA2523413A1 (en) | 2003-04-25 | 2004-11-11 | The Penn State Research Foundation | Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds |
ES2559828T3 (es) * | 2003-07-16 | 2016-02-16 | Protiva Biotherapeutics Inc. | ARN de interferencia encapsulado en lípidos |
NZ581166A (en) * | 2003-09-15 | 2011-06-30 | Protiva Biotherapeutics Inc | Polyethyleneglycol-modified lipid compounds and uses thereof |
CA2559853A1 (en) * | 2004-02-17 | 2005-10-13 | University Of South Florida | Materials and methods for treatment of inflammatory and cell proliferation disorders |
US20050181035A1 (en) * | 2004-02-17 | 2005-08-18 | Dow Steven W. | Systemic immune activation method using non CpG nucleic acids |
AU2005252273B2 (en) * | 2004-06-07 | 2011-04-28 | Arbutus Biopharma Corporation | Lipid encapsulated interfering RNA |
US20060116270A1 (en) * | 2004-07-16 | 2006-06-01 | Mehdi Hatamian | Centrifuge system |
US7744920B2 (en) * | 2004-09-09 | 2010-06-29 | Hadasit Medical Research Services & Development Limited | Use of liposomal glucocorticoids for treating inflammatory states |
US20080063702A1 (en) * | 2004-09-09 | 2008-03-13 | Yechezkel Barenholz | Liposomal Formulations Comprising an Amphipathic Weak Base Like Tempamine for Treatment of Neurodegenerative Conditions |
AU2005303389A1 (en) * | 2004-11-15 | 2006-05-18 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Combination therapy associating preferably a ceramide with a cytotoxic drug |
WO2006066158A2 (en) * | 2004-12-14 | 2006-06-22 | Alnylam Pharmaceuticals, Inc. | Rnai modulation of mll-af4 and uses thereof |
WO2006086992A2 (en) * | 2005-02-18 | 2006-08-24 | Liplasome Pharma A/S | Drug delivery systems containing phqspholipase a2 degradable lipid prodrug derivatives and the therapeutic uses thereof as. e.g. wound healing agents and peroxisome proliferator activated receptor ligands |
EP1962796A2 (en) * | 2005-12-08 | 2008-09-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods for affecting liposome composition by ultrasound irradiation |
US20070218116A1 (en) * | 2006-03-14 | 2007-09-20 | Schwendener Reto A | Compositions and methods for the treatment of tumors and tumor metastases |
WO2007127487A2 (en) * | 2006-04-28 | 2007-11-08 | University Of South Florida | Materials and methods for reducing inflammation by inhibition of the atrial natriuretic peptide receptor |
WO2007127428A2 (en) * | 2006-04-28 | 2007-11-08 | University Of Florida Research Foundation, Inc. | Double-stranded/self-complementary vectors with a truncated cba promoter and methods of gene delivery |
CA2600220C (en) * | 2006-09-07 | 2014-12-09 | Canadian Blood Services | Surface cross-linked lipidic particles, methods of production and uses therefor |
WO2009127060A1 (en) | 2008-04-15 | 2009-10-22 | Protiva Biotherapeutics, Inc. | Novel lipid formulations for nucleic acid delivery |
EP2440250A1 (en) | 2009-06-11 | 2012-04-18 | Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. | Targeted liposomes comprising n-containing bisphosphonates and uses thereof |
US9018187B2 (en) | 2009-07-01 | 2015-04-28 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
US8569256B2 (en) | 2009-07-01 | 2013-10-29 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
IL292615B2 (en) | 2009-07-01 | 2023-11-01 | Protiva Biotherapeutics Inc | Nucleic acid-lipid particles, preparations containing them and their uses |
US20130052259A1 (en) | 2010-02-01 | 2013-02-28 | Yechezkel Barenholz | Liposomes comprising amphipathic drugs and method for their preparation |
US9006417B2 (en) | 2010-06-30 | 2015-04-14 | Protiva Biotherapeutics, Inc. | Non-liposomal systems for nucleic acid delivery |
EP2651448B1 (en) | 2010-12-13 | 2018-11-28 | QuiaPEG Pharmaceuticals AB | Water-soluble, non-peptidic, non-nucleotidic phosphoramidate functionalized polymers |
US10184942B2 (en) | 2011-03-17 | 2019-01-22 | University Of South Florida | Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer |
ES2819059T3 (es) | 2011-07-13 | 2021-04-14 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Liposomas que encapsulan conjuntamente un bifosfonato y un agente anfipático |
CA2876315C (en) | 2012-06-12 | 2021-05-25 | Marek Kwiatkowski | Conjugates of biologically active molecules to functionalized polymers |
EP3247333B1 (en) | 2015-01-20 | 2021-07-21 | Tetraderm Group LLC | Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration |
WO2016149516A1 (en) | 2015-03-17 | 2016-09-22 | Lipomedix Pharmaceuticals Ltd. | Methods for the treatment of bladder cancer |
CN105439827A (zh) * | 2016-01-12 | 2016-03-30 | 江苏省计量科学研究院 | 一种1,2-O-双十六烷基-rac-甘油的合成方法 |
EP4011396A1 (en) | 2017-03-10 | 2022-06-15 | QuiaPEG Pharmaceuticals AB | Releasable conjugates |
JP2021535920A (ja) | 2018-09-12 | 2021-12-23 | キアペグ ファーマシューティカルズ アクチエボラグ | 放出可能なglp−1コンジュゲート |
FR3089814B1 (fr) * | 2018-12-18 | 2021-04-02 | Oreal | Procede de traitement des fibres keratiniques comprenant l’application d’un agent de couplage et d’un phospholipide, composition et utilisation |
AU2021385572A1 (en) | 2020-11-25 | 2023-06-22 | Akagera Medicines, Inc. | Lipid nanoparticles for delivery of nucleic acids, and related methods of use |
CN114796055B (zh) * | 2022-05-19 | 2023-08-15 | 广东艾粒生物科技有限责任公司 | 富含脂质体纳米粒的美白敷料及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2408387A2 (fr) * | 1975-06-30 | 1979-06-08 | Oreal | Compositions a base de dispersions aqueuses de spherules lipidiques |
US4426330A (en) * | 1981-07-20 | 1984-01-17 | Lipid Specialties, Inc. | Synthetic phospholipid compounds |
US4534899A (en) * | 1981-07-20 | 1985-08-13 | Lipid Specialties, Inc. | Synthetic phospholipid compounds |
US5153000A (en) * | 1988-11-22 | 1992-10-06 | Kao Corporation | Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome |
US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
DE69103487T2 (de) * | 1990-07-11 | 1995-02-16 | Quest Int | Parfümierte strukturierte Emulsionen in Körperpflegemitteln. |
FR2676924B1 (fr) * | 1991-05-31 | 1995-02-03 | Saint Laurent Parfums Yves | Microemulsion contenant un concentre parfumant et produit correspondant. |
JPH07316040A (ja) * | 1994-03-29 | 1995-12-05 | Res Dev Corp Of Japan | 再構成リポソームと物質導入方法 |
US5817856A (en) * | 1995-12-11 | 1998-10-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Radiation-protective phospholipid and method |
-
1995
- 1995-12-11 US US08/570,440 patent/US5817856A/en not_active Expired - Lifetime
-
1996
- 1996-12-10 IL IL12473296A patent/IL124732A0/xx not_active IP Right Cessation
- 1996-12-10 DE DE69620473T patent/DE69620473T2/de not_active Expired - Lifetime
- 1996-12-10 AU AU77075/96A patent/AU705529B2/en not_active Ceased
- 1996-12-10 AT AT96940103T patent/ATE215360T1/de not_active IP Right Cessation
- 1996-12-10 ES ES96940103T patent/ES2175152T3/es not_active Expired - Lifetime
- 1996-12-10 EP EP96940103A patent/EP0900075B1/en not_active Expired - Lifetime
- 1996-12-10 WO PCT/IL1996/000175 patent/WO1997021429A1/en active IP Right Grant
-
1998
- 1998-10-06 US US09/167,403 patent/US6165501A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE215360T1 (de) | 2002-04-15 |
EP0900075B1 (en) | 2002-04-03 |
AU7707596A (en) | 1997-07-03 |
DE69620473D1 (de) | 2002-05-08 |
US6165501A (en) | 2000-12-26 |
AU705529B2 (en) | 1999-05-27 |
DE69620473T2 (de) | 2002-11-14 |
IL124732A0 (en) | 1999-01-26 |
EP0900075A1 (en) | 1999-03-10 |
WO1997021429A1 (en) | 1997-06-19 |
US5817856A (en) | 1998-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2175152T3 (es) | Fosfolipidos protectores de las radiaciones. | |
EA199900486A1 (ru) | Применение сфингомиелиназы для повышения уровней церамидов в коже и слизистых оболочках, а также содержащие ее дерматологические и косметические композиции, которые удобны для местного применения | |
ES2054278T3 (es) | Utilizacion y composiciones cosmeticas que contienen diorganopolisiloxanos con funcion benzotriazol para la proteccion de la piel y los cabellos. | |
IT8367659A0 (it) | Nuove 3 benzilidencanfore loro procedimento di preparazione e loro utilizzazione per la protezione con tro i raggi ultravioletti | |
AU653999B2 (en) | Compositions having a physiological cooling effect, and active compounds suitable for these compositions | |
ES2162951T3 (es) | Estabilizacion de composiciones de prostaglandina. | |
BR9509648A (pt) | Combinações de herbicidas de fenilsulfoniluréia e protetores | |
ITMI950493A0 (it) | Frazioni polifenoliche di te' loro uso e formulazioni che le contengono | |
ES2126887T3 (es) | Composiciones bronceadoras artificiales con estabilidad mejorada. | |
DE69419909D1 (de) | Flammhemmende im wesentlichen halogenfreie epoxydzusammensetzung | |
AR000271A1 (es) | Composiciones cosméticas par uso tópico utilizables para el bronceado y/o el tostado artificiales dela piel | |
EA200000181A1 (ru) | Фармацевтические композиции, содержащие витамин d и кальций, их приготовление и терапевтическое применение | |
ES2191932T3 (es) | Composiciones cosmeticas que contienen un polimero cationico de baja masa molecular y una silicona y sus utilizaciones. | |
DE69428456D1 (de) | Silikon-modifizierte phospholipid-zusammensetzungen | |
ES2135169T3 (es) | Cable resistente a las arborescencias. | |
ES2057004T3 (es) | N-alcoxialquilamidas de hidroxiacidos y composiciones a base de las mismas para el tratamiento de la piel. | |
WO1997016155A3 (en) | Cosmetic and cosmeceutical compositions | |
DK0487973T3 (da) | Topisk lotion indeholdende niclosamid | |
AU3169089A (en) | Use of diorganopolysiloxanes containing a 3-benzylidene- camphor functional group in cosmetics and new cosmetic compositions containing these compounds, intended for protecting the skin and hair | |
ES2073878T3 (es) | Utilizacion de la lactoferrina para la proteccion de la queratina de los cabellos contra las agresiones atmosfericas, en particular la luz, y procedimiento de proteccion de los cabellos utilizando ese compuesto. | |
DK0801571T3 (da) | Opløselige 2'-chlor-2'-deoxyadenosion-formuleringer | |
KR980700053A (ko) | TiO₂나노피그먼트 및 아실아미노산을 함유하는 자외선-차단 화장품용 조성물(Ultraviolet-Protecting Cosmetic Compositions Containing TiO₂Nanopigments and an Acylaminoacid) | |
FI925930A0 (fi) | En kosmetisk eller dermatologisk blandning innehaollande en diolester | |
NO20001352D0 (no) | Hårkondisjoneringsblanding omfattende esterolje med høy molekylvekt | |
ATE300278T1 (de) | Snf2 gel mit verbesserter formfestigkeit und stabilität |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 900075 Country of ref document: ES |